BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Feng L, Zhu Y, Zhang Y, Rao M. LncRNA GACAT3 promotes gastric cancer progression by negatively regulating miR-497 expression. Biomedicine & Pharmacotherapy 2018;97:136-42. [DOI: 10.1016/j.biopha.2017.10.074] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Xie G, Ke Q, Ji YZ, Wang AQ, Jing M, Zou LL. FGFR1 is an independent prognostic factor and can be regulated by miR-497 in gastric cancer progression. Braz J Med Biol Res 2018;52:e7816. [PMID: 30484492 DOI: 10.1590/1414-431X20187816] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
2 Li W, Chen QF, Huang T, Wu P, Shen L, Huang ZL. Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma. Front Oncol 2020;10:780. [PMID: 32587825 DOI: 10.3389/fonc.2020.00780] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
3 Chen W, Zhu Y, Zhang W, Zhang H, Zhou Y, Sun P, Wu G. CDC42EP3 is a key promoter involved in the development and progression of gastric cancer. Carcinogenesis 2021:bgab048. [PMID: 34111280 DOI: 10.1093/carcin/bgab048] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Yuan X, Dong Z, Shen S. LncRNA GACAT3: A Promising Biomarker and Therapeutic Target in Human Cancers. Front Cell Dev Biol 2022;10:785030. [DOI: 10.3389/fcell.2022.785030] [Reference Citation Analysis]
5 Wei LQ, Li L, Lu C, Liu J, Chen Y, Wu H. Involvement of H19/miR-326 axis in hepatocellular carcinoma development through modulating TWIST1. J Cell Physiol 2019;234:5153-62. [PMID: 30362512 DOI: 10.1002/jcp.27319] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
6 Wang Y, Yang F, Yang Q. The regulatory roles and potential prognosis implications of long non-coding RNAs in gastric cancer. Histol Histopathol 2020;35:433-42. [PMID: 31793657 DOI: 10.14670/HH-18-188] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Luo G, He K, Xia Z, Liu S, Liu H, Xiang G. Regulation of microRNA-497 expression in human cancer. Oncol Lett 2021;21:23. [PMID: 33240429 DOI: 10.3892/ol.2020.12284] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
8 Zhong H, Yang J, Zhang B, Wang X, Pei L, Zhang L, Lin Z, Wang Y, Wang C. LncRNA GACAT3 predicts poor prognosis and promotes cell proliferation in breast cancer through regulation of miR-497/CCND2. Cancer Biomark 2018;22:787-97. [PMID: 29945347 DOI: 10.3233/CBM-181354] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
9 Tang Y, Zhong Z, Wang X, Wang Y, Liu Y, Chang Z. microRNA-497 inhibition mitigates myocardial infarction via enhancing wingless/integrated signal pathway in bone marrow mesenchymal stem cells. J Cell Biochem 2019;120:13403-12. [PMID: 30927382 DOI: 10.1002/jcb.28615] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Bu JY, Lv WZ, Liao YF, Xiao XY, Lv BJ. Long non-coding RNA LINC00978 promotes cell proliferation and tumorigenesis via regulating microRNA-497/NTRK3 axis in gastric cancer. Int J Biol Macromol 2019;123:1106-14. [PMID: 30452981 DOI: 10.1016/j.ijbiomac.2018.11.162] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
11 Gao S, Zhao ZY, Wu R, Zhang Y, Zhang ZY. Prognostic value of long noncoding RNAs in gastric cancer: a meta-analysis. Onco Targets Ther 2018;11:4877-91. [PMID: 30147339 DOI: 10.2147/OTT.S169823] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 6.3] [Reference Citation Analysis]
12 Zhang Z, Chen J, Zhu Z, Zhu Z, Liao X, Wu J, Cheng J, Zhang X, Mei H, Yang G. CRISPR-Cas13-Mediated Knockdown of lncRNA-GACAT3 Inhibited Cell Proliferation and Motility, and Induced Apoptosis by Increasing p21, Bax, and E-Cadherin Expression in Bladder Cancer. Front Mol Biosci 2020;7:627774. [PMID: 33537343 DOI: 10.3389/fmolb.2020.627774] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
13 Xu G, Zhang Y, Li N, Wu Y, Zhang J, Xu R, Ming H. LBX2-AS1 up-regulated by NFIC boosts cell proliferation, migration and invasion in gastric cancer through targeting miR-491-5p/ZNF703. Cancer Cell Int 2020;20:136. [PMID: 32351330 DOI: 10.1186/s12935-020-01207-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
14 Guo Y, Zhang H, Xie D, Hu X, Song R, Zhu L. Non-coding RNA NEAT1/miR-214-3p contribute to doxorubicin resistance of urothelial bladder cancer preliminary through the Wnt/β-catenin pathway. Cancer Manag Res 2018;10:4371-80. [PMID: 30349370 DOI: 10.2147/CMAR.S171126] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 3.8] [Reference Citation Analysis]
15 Yang J, Xu QC, Wang ZY, Lu X, Pan LK, Wu J, Wang C. Integrated Analysis of an lncRNA-Associated ceRNA Network Reveals Potential Biomarkers for Hepatocellular Carcinoma. J Comput Biol 2021;28:330-44. [PMID: 33185458 DOI: 10.1089/cmb.2019.0250] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Zhang Q, Ning G, Jiang H, Huang Y, Piao J, Chen Z, Tan X, Zhang J, Liu G. 15-lncRNA-Based Classifier-Clinicopathologic Nomogram Improves the Prediction of Recurrence in Patients with Hepatocellular Carcinoma. Dis Markers 2020;2020:9180732. [PMID: 33520012 DOI: 10.1155/2020/9180732] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
17 Nie ML, Han J, Huang HC, Guo T, Huangfu LT, Cheng XJ, Li XM, Du H, Li QD, Wen XZ, Ji JF. The novel lncRNA p4516 acts as a prognostic biomarker promoting gastric cancer cell proliferation and metastasis. Cancer Manag Res 2019;11:5375-91. [PMID: 31354346 DOI: 10.2147/CMAR.S201793] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
18 Fattahi S, Kosari-Monfared M, Golpour M, Emami Z, Ghasemiyan M, Nouri M, Akhavan-Niaki H. LncRNAs as potential diagnostic and prognostic biomarkers in gastric cancer: A novel approach to personalized medicine. J Cell Physiol. 2020;235:3189-3206. [PMID: 31595495 DOI: 10.1002/jcp.29260] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 10.0] [Reference Citation Analysis]
19 Ghafouri-Fard S, Taheri M. Long non-coding RNA signature in gastric cancer. Exp Mol Pathol 2020;113:104365. [PMID: 31899194 DOI: 10.1016/j.yexmp.2019.104365] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
20 Dong L, Zhu K, Chen M, Li D, Jiang C, Chen L. Long non-coding RNA GACAT3 promotes liver cancer progression by regulating the proliferation, apoptosis and migration of tumor cells. Exp Ther Med 2020;19:3377-83. [PMID: 32266036 DOI: 10.3892/etm.2020.8604] [Cited by in F6Publishing: 1] [Reference Citation Analysis]